(Q34255750)

31 July 2017

title

REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility (English)

1 reference

31 July 2017

1 reference

1 reference

S Zhang

1

1 reference

31 July 2017

H Chen

2

1 reference

31 July 2017

X Zhao

3

1 reference

31 July 2017

J Cao

4

1 reference

31 July 2017

J Tong

5

1 reference

31 July 2017

J Lu

6

1 reference

31 July 2017

W Wu

7

1 reference

31 July 2017

H Shen

8

1 reference

31 July 2017

Q Wei

9

1 reference

31 July 2017

D Lu

10

1 reference

31 July 2017

language of work or name

English

0 references

publication date

20 February 2012

1 reference

31 July 2017

1 reference

31 July 2017

volume

32

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

242-250

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.32

31 July 2017

exact match

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Trading places: how do DNA polymerases switch during translesion DNA synthesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Generation of mutator mutants during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Low fidelity DNA synthesis by human DNA polymerase-eta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Preferential incorporation of G opposite template T by the low-fidelity human DNA polymerase iota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

DNA polymerase zeta (pol zeta) in higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Mutagenesis in eukaryotes dependent on DNA polymerase zeta and Rev1p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Potential uses of microRNA in lung cancer diagnosis, prognosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Replication of damaged DNA by translesion synthesis in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

A full-length cDNA of hREV3 is predicted to encode DNA polymerase zeta for damage-induced mutagenesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Molecular characterization of seizure-related genes isolated by differential screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Functional analysis of p53 binding under differential stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

21 January 2018

Genomics of microRNA.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Specificity of microRNA target selection in translational repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

A novel method to detect functional microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Human polymorphism at microRNAs and microRNA target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Genetic variants in peroxisome proliferator-activated receptor-gamma gene are associated with risk of lung cancer in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Induction of forward mutations in mutationally defective yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

Association of increased spontaneous mutation rates with high levels of transcription in yeast

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.32

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.32

1 reference

Dimensions Publication ID

31 July 2017

1046907119

0 references

1 reference